Skip to main content
Clinical Trials/CTRI/2022/09/045346
CTRI/2022/09/045346
Not yet recruiting
Phase 2

Evaluation of efficacy of prophylactic intermittent zinc supplementation in reducing the incidence of acute lower respiratory infections and acute diarrhoea in infants: A hospital based, open label randomized control trial

Dr Arnab Ghorui0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Arnab Ghorui
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Arnab Ghorui

Eligibility Criteria

Inclusion Criteria

  • Infants of age between 6 wks to 6 months coming for vaccination as per National Immunization Schedule

Exclusion Criteria

  • 1\. Children received zinc supplementation in past 2months
  • 2\. Children with severe illness requiring hospitalization
  • 3\. Infants with weight and height for age \< \-3 SD
  • Suspected Malabsorption syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials